Horizon Pharma’s Bid for Depomed Leaves Room to Grow by ROBERT CYRAN

By ROBERT CYRAN

Horizon Pharma is a recent entrant on the merger scene, so its low debt load and small size mean it can easily expand. Look for more deals to come.

Published: July 8, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1LQMN4Y

from WordPress http://ift.tt/1CYWVBq
via Hadi Aboukhater